Table 1.
Demographic and clinical characteristics patients.
| Variable | Placebo (N = 130) | Bosentan (N = 129) | Total (N = 259) |
|---|---|---|---|
| Age, Year | 45.99 ± 13.20 | 45.73 ± 11.29 | 45.86 ± 12.26 |
| Male | 73 (56.2) | 79 (61.2) | 152 (58.7) |
| Risk factors | |||
| Age ≥ 50 years | 55 (52.4) | 50 (47.6) | 105 (40.5) |
| BMI ≥ 25 | 67 (51.5) | 63 (48.5) | 130 (50.2) |
| Diabetes Mellitus | 80 (61.5) | 82 (63.5) | 162 (62.5) |
| Hypertension | 50 (38.5) | 39 (30.2) | 89 (34.4) |
| Tobacco or Nicotine User | 19 (14.6) | 24 (18.6) | 43 (16.6) |
| Serious heart condition | 5 (3.8) | 7 (5.4) | 12 (4.6) |
| COPD | 12 (9.2) | 11 (8.5) | 23 (8.9) |
| Number of risk factors | |||
| 1 | 28 (21.5) | 37 (28.7) | 65 (25.1) |
| 2 | 58 (44.6) | 49 (38) | 107 (41.3) |
| 3 | 37 (28.5) | 39 (30.2) | 76 (29.3) |
| 4 | 7 (5.4) | 4 (3.1) | 11 (4.2) |
| Days from illness onset to admission | 3 (2–3) | 3 (2–3) | 3 (2–3) |
BMI, Body Mass Index; COPD, Chronic obstructive pulmonary disease.
Data are reported as X2 test (n, %), T test (mean, SD) or Median (Q1–Q3).